NCT04394351 Study to Investigate the Efficacy and Safety of Dupilumab in Pediatric Patients With Active Eosinophilic Esophagitis (EoE) Status COMPLETED Phase PHASE3
NCT04373083 Anti-PD-1 Antibody Treatment With Cemiplimab and Radiotherapy in Early-stage Classical Hodgkin Lymphoma Status WITHDRAWN Phase PHASE2
NCT04368429 Study of a Quadrivalent Meningococcal Conjugate Vaccine as a Single Dose Compared With a Single Dose of a Meningococcal Reference Vaccine in Children, Adolescents, and Adults 2 to 55 Years of Age Status COMPLETED Phase PHASE3
NCT04349306 Evaluate the Efficacy and Safety of Rasburicase (Fasturtec®) in the Prevention and Treatment of Hyperuricemia in Pediatric Patients With Non-Hodgkin's Lymphoma and Acute Leukemia Status COMPLETED Phase PHASE4
NCT04315298 Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19 Status COMPLETED Phase PHASE2/PHASE3
NCT04294459 Safety, Pharmacokinetics, and Preliminary Efficacy of Isatuximab in Patients Awaiting Kidney Transplantation Status TERMINATED Phase PHASE1/PHASE2
NCT04287855 Multicenter Open Label Phase 2 Study of Isatuximab Plus Pomalidomide and Dexamethasone With Carfilzomib in Relapsed or Refractory Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04287608 Observational Study of Conjunctivitis in the Setting of DUPIXENT® Treatment for Atopic Dermatitis Status COMPLETED Phase N/A
NCT04276623 Identifying Atopic Dermatitis Patients at Risk for Developing Conjunctivitis During Dupilumab Treatment Status RECRUITING Phase N/A
NCT04270409 Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04239599 Trial of Hypofractionated IMRT Boost Versus Conventional IMRT Boost for Localized High Risk Prostate Cancer Status UNKNOWN Phase NA
NCT04219514 Investigating Novel Predictions of Hypoglycemia Occurrence in Real-world Models Status COMPLETED Phase N/A
NCT04216875 Best Practice Study of Diabetes Type 2 Management in Primary Care in Switzerland Status COMPLETED Phase N/A
NCT04206553 A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Bullous Pemphigoid Status COMPLETED Phase PHASE2/PHASE3
NCT04202679 Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (PRIME2) Status COMPLETED Phase PHASE3
NCT04191382 Phase 2 Window Study of SAR439859 (Amcenestrant) Versus Letrozole in Post-menopausal Patients With ER+, HER2- Pre-operative Post-menopausal Primary Breast Cancer Status TERMINATED Phase PHASE2